HIV治療薬の世界市場レポート（2022年）

レポートナンバー　0000031676

HIV治療薬の世界市場レポート（2022年）

The Business Research Company

HIV Drugs Global Market Report 2022

発刊日 2022/03/02

言語英語

体裁PDF/175ページ

ライセンス/価格175ページ

0000031676

Single	5,000USD
Site	7,500USD
Enterprise	10,000USD

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※受注後、レポートは最新版へ更新されますので、納品までに3〜5営業日かかります。

お問い合わせ

サンプル依頼

無料サンプル

サンプルはお問い合わせください。

レポート概要

本レポートは、HIV治療薬市場とCovid19ウイルスによる市場への影響をカバーしています。戦略担当者、マーケティング担当者、経営幹部に、Covid19患者の治療に重要な役割を果たすHIV治療薬の需要の高まりを評価するために必要な重要な情報を提供します。

調査範囲

調査市場
➣ タイプ別
　　◇ ヌクレオシド逆転写酵素阻害薬（NRT）
　　◇ 非ヌクレオシド逆転写酵素阻害薬（NNRT）
　　◇ プロテアーゼ阻害薬
　　◇ インテグラーゼ阻害薬
　　◇ フュージョン阻害薬
　　◇ ケモカイン受容体阻害薬
　　◇ その他
➣ アプリケーション別
　　◇ 病院薬局
　　◇ 小売薬局
　　◇ オンライン薬局
　　◇ その他
➣ 投与経路別
　　◇ 経口
　　◇ 非経口
　　◇ その他
➣ 調査企業
　　◇ ViiV Healthcare
　　◇ Gilead Sciences
　　◇ Merck & Co., Inc.
　　◇ Bristol-Myers Squibb Company
　　◇ Janssen (Johnson&Johnson)
➣ 調査国
　　◇ ブラジル、中国、フランス、ドイツ、インド、インドネシア、日本、韓国、ロシア、イギリス、アメリカ、オーストラリア
調査地域
➣ アジア太平洋地域
➣ 西ヨーロッパ
➣ 東ヨーロッパ
➣ 北アメリカ
➣ 南アメリカ
➣ 中東
➣ アフリカ
調査期間
➣ 5年間の実績データおよび10年間の予測
データ
➣ 市場規模と成長率の関連市場に対する比率
➣ GDP比率
➣ 一人当たりの支出
➣ HIV治療薬指標の比較
データセグメント
➣ 国別・地域別の実績および予測データ
➣ 競合企業の市場シェア
➣ 市場セグメント
情報源および参照
➣ 本レポートのデータおよび分析は、注釈で出典を明らかにしています。

レポート詳細

6. HIV Drugs Market Segmentation
6.1. Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Nucleoside Reverse Transcriptase Inhibitors (NRT's)
Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT's)
Protease Inhibitors
Integrate Inhibitors
Fusion Inhibitors
Chemokine Receptor Inhibitors
Others
6.2. Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
6.3. Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Oral
Parenteral

7. HIV Drugs Market Regional And Country Analysis
7.1. Global HIV Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
7.2. Global HIV Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

8. Asia-Pacific HIV Drugs Market
8.1. Asia-Pacific HIV Drugs Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

9. China HIV Drugs Market
9.1. China HIV Drugs Market Overview
9.2. China HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F,$ Billion

10. India HIV Drugs Market
10.1. India HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

11. Japan HIV Drugs Market
11.1. Japan HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

12. Australia HIV Drugs Market
12.1. Australia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

13. Indonesia HIV Drugs Market
13.1. Indonesia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

14. South Korea HIV Drugs Market
14.1. South Korea HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

15. Western Europe HIV Drugs Market
15.1. Western Europe HIV Drugs Market Overview
15.2. Western Europe HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

16. UK HIV Drugs Market
16.1. UK HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

17. Germany HIV Drugs Market
17.1. Germany HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

18. France HIV Drugs Market
18.3. France HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

19. Eastern Europe HIV Drugs Market
19.1. Eastern Europe HIV Drugs Market Overview
19.2. Eastern Europe HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

20. Russia HIV Drugs Market
20.1. Russia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

21. North America HIV Drugs Market
21.1. North America HIV Drugs Market Overview
21.2. North America HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

22. USA HIV Drugs Market
22.1. USA HIV Drugs Market Overview
22.2. USA HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

23. South America HIV Drugs Market
23.1. South America HIV Drugs Market Overview
23.2. South America HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

24. Brazil HIV Drugs Market
24.1. Brazil HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

25. Middle East HIV Drugs Market
25.1. Middle East HIV Drugs Market Overview
25.2. Middle East HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

26. Africa HIV Drugs Market
26.1. Africa HIV Drugs Market Overview
26.2. Africa HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion

27. HIV Drugs Market Competitive Landscape And Company Profiles
27.1. HIV Drugs Market Competitive Landscape
27.2. HIV Drugs Market Company Profiles
27.2.1. ViiV Healthcare
27.2.1.1. Overview
27.2.1.2. Products and Services
27.2.1.3. Strategy
27.2.1.4. Financial Performance
27.2.2. Gilead Sciences
27.2.2.1. Overview
27.2.2.2. Products and Services
27.2.2.3. Strategy
27.2.2.4. Financial Performance
27.2.3. Merck & Co., Inc.
27.2.3.1. Overview
27.2.3.2. Products and Services
27.2.3.3. Strategy
27.2.3.4. Financial Performance
27.2.4. Bristol-Myers Squibb Company
27.2.4.1. Overview
27.2.4.2. Products and Services
27.2.4.3. Strategy
27.2.4.4. Financial Performance
27.2.5. Janssen (Johnson&Johnson)
27.2.5.1. Overview
27.2.5.2. Products and Services
27.2.5.3. Strategy
27.2.5.4. Financial Performance

28. HIV Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The HIV Drugs Market

30. HIV Drugs Market Future Outlook and Potential Analysis

31. Appendix
31.1. Abbreviations
31.2. Currencies
31.3. Research Inquiries
31.4. The Business Research Company
31.5. Copyright And Disclaimer

Table of Contents
Table 1: Global Historic Market Growth, 2016-2021, $ Billion
Table 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Table 3: Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 4: Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 5: Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 6: Global HIV Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 7: Global HIV Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 8: Asia-Pacific, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 9: China, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 10: India, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 11: Japan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 12: Australia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 13: Indonesia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 14: South Korea, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 15: Western Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 16: UK, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 17: Germany, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 18: France, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 19: Eastern Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 20: Russia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 21: North America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 22: USA, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 23: South America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 24: Brazil, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 25: Middle East, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 26: Africa, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Table 27: ViiV Healthcare Financial Performance
Table 28: Gilead Sciences Financial Performance
Table 29: Merck & Co., Inc. Financial Performance
Table 30: Bristol-Myers Squibb Company Financial Performance
Table 31: Janssen (Johnson&Johnson) Financial Performance

List of Figures
Figure 1: Global Historic Market Growth, 2016-2021, $ Billion
Figure 2: Global Forecast Market Growth, 2021-2026F, 2031F, $ Billion
Figure 3: Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 4: Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 5: Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 6: Global HIV Drugs Market, Split By Region, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 7: Global HIV Drugs Market, Split By Country, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 8: Asia-Pacific, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 9: China, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 10: India, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 11: Japan, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 12: Australia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 13: Indonesia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 14: South Korea, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 15: Western Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 16: UK, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 17: Germany, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 18: France, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 19: Eastern Europe, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 20: Russia, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 21: North America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 22: USA, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 23: South America, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 24: Brazil, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 25: Middle East, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 26: Africa, HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2016-2021, 2021-2026F, 2031F, $ Billion
Figure 27: ViiV Healthcare Financial Performance
Figure 28: Gilead Sciences Financial Performance
Figure 29: Merck & Co., Inc. Financial Performance
Figure 30: Bristol-Myers Squibb Company Financial Performance
Figure 31: Janssen (Johnson&Johnson) Financial Performance

お買い物ガイド

よくある質問

この商品のレポートナンバー

0000031676

国内・海外の市場調査レポート販売

世界中の市場調査レポートを販売！当社に無いレポートもお探しします。